drugset / Trial / NCT01675115

Efficacy of BNG-1 to Treat Acute Ischemic Stroke

NCT01675115 ↗

Phase 3 Completed 129 enrolled Chang Gung Memorial Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this study is to investigate the efficacy and safety of BNG-1 in patients with ischemic stroke. The efficacy assessment will be based on the functional outcome while the safety will be reviewed by the adverse events and laboratory examinations.

Timeline

Start
2012-08
Primary completion
2014-11
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator BNG-1 Unknown 3 g —
Comparator Aspirin Small molecule 100 mg —

Indications